These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 27742785)

  • 21. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
    Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
    Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study.
    Williamson SK; Lew D; Miller GJ; Balcerzak SP; Baker LH; Crawford ED
    Cancer; 2000 Mar; 88(5):1159-65. PubMed ID: 10699907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenocortical cancer treatment.
    Patalano A; Brancato V; Mantero F
    Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Developing treatment for adrenocortical carcinoma.
    Kerkhofs TM; Ettaieb MH; Hermsen IG; Haak HR
    Endocr Relat Cancer; 2015 Dec; 22(6):R325-38. PubMed ID: 26259571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma.
    Else T; Williams AR; Sabolch A; Jolly S; Miller BS; Hammer GD
    J Clin Endocrinol Metab; 2014 Feb; 99(2):455-61. PubMed ID: 24302750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Next-generation therapies for adrenocortical carcinoma.
    Altieri B; Ronchi CL; Kroiss M; Fassnacht M
    Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101434. PubMed ID: 32622829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?
    Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric adrenocortical carcinoma.
    Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J
    Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
    Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
    J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adjuvant mitotane treatment for adrenocortical carcinoma.
    Terzolo M; Angeli A; Fassnacht M; Daffara F; Tauchmanova L; Conton PA; Rossetto R; Buci L; Sperone P; Grossrubatscher E; Reimondo G; Bollito E; Papotti M; Saeger W; Hahner S; Koschker AC; Arvat E; Ambrosi B; Loli P; Lombardi G; Mannelli M; Bruzzi P; Mantero F; Allolio B; Dogliotti L; Berruti A
    N Engl J Med; 2007 Jun; 356(23):2372-80. PubMed ID: 17554118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options.
    Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M
    Expert Rev Anticancer Ther; 2018 Nov; 18(11):1125-1133. PubMed ID: 30117750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitotane treatment for adrenocortical carcinoma: an overview.
    De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
    Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-Target Approach to Metastatic Adrenal Cell Carcinoma.
    Wahab NA; Zainudin S; AbAziz A; Mustafa N; Sukor N; Kamaruddin NA
    Arch Iran Med; 2016 Sep; 19(9):671-3. PubMed ID: 27631184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of adrenocortical carcinomas in children].
    Leblond P; Delebarre M; Aubert S
    Bull Cancer; 2011 May; 98(5):595-605. PubMed ID: 21596653
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Three Cases of Advanced or Recurrent Adrenocortical Carcinoma Patients Treated with Etoposide, Doxorubicin and Cisplatin plus Mitotane].
    Sasaki S
    Gan To Kagaku Ryoho; 2018 Jan; 45(1):67-70. PubMed ID: 29362311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenocortical carcinoma.
    van Ditzhuijsen CI; van de Weijer R; Haak HR
    Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical management of adrenocortical carcinoma.
    Fassnacht M; Allolio B
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):273-89. PubMed ID: 19500769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis and treatment for adrenocortical carcinoma].
    Iihara M; Obara T
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):342-5. PubMed ID: 15045937
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical study and treatment results of adrenocortical carcinoma patients presented in Shaukat Khanum Memorial Cancer Hospital and Research Center, Lahore.
    Khan MS; Ali A; Tariq I; Khan MA; Bakar MA; Anwar AW
    J Pak Med Assoc; 2019 May; 69(5):717-719. PubMed ID: 31105294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical management of malignant adrenal tumors.
    Kopf D; Goretzki PE; Lehnert H
    J Cancer Res Clin Oncol; 2001; 127(3):143-55. PubMed ID: 11260859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.